|
Synopsis
Attrition due to safety/toxicity remains a challenge in drug discovery and development. Strategies to improve
success focus on asking the right questions at the right time around Target, Chemistry and Patient with an emphasis
on translation of data to the clinic.
This one day meeting will bring together experts in each of these areas to discuss current thinking on
enhancing probability of success illustrated by case studies.
Registration, Students, and Bursaries
Registration for this meeting is free of charge and will open here in
January 2019. For non-members, please email Tim for help with registration via
t.schulz-utermoehl@sygnaturediscovery.com
Call for Posters and short Presentations
The call for papers is now open, and abstracts are invited for both short talks (5min) and posters. The closing date for a talk is: 31st January 2019 and a poster is 28th February 2019; please email an abstract and with the subject “Predictive Tox Abstract” with title, authors and respective affiliations
to t.schulz-utermoehl@sygnaturediscovery.com.
Posters should be portrait, A0.
Who should attend?
It will be of interest to those from academia, Pharma (large and small) and to CROs who wish to contribute their expertise and to learn more about new developments in drug discovery and development.
Sponsorship and Exhibitors
Sponsorship and Exhibitor opportunities are available. Please request a sponsorship pack from Tim via
t.schulz-utermoehl@sygnaturediscovery.com
Venue
Alderley Park Conference Centre, Alderley Park, Cheshire SK10 4TG, United Kingdom.
There are direct train services from London to Wilmslow station, which is a short journey by taxi to the conference centre. For those coming from Europe, Manchester Airport is also a short journey by taxi to the venue. For those driving, visitor parking will be available on site.
Accommodation
Should you require recommendations for local hotels, please email Tim via
t.schulz-utermoehl@sygnasturediscovery.com
Organising Committee
Jamie Henshall, UCB and the DMDG
Lyndsey Edwards, Jamie Patient and Timothy Schulz-Utermoehl, Sygnature Discovery
Ruth Roberts, ApconiX
Clive Dilworth, Alderley Park
|
